Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Weight Loss 2Pancreatic Neoplasms 1Neoplasm Metastasis 1Cachexia 1Anorexia 1

Interventions

anamorelin 2Mirtazapine 2Tirzepatide 1Olanzapine 1Octreotide 1Nutritionists 1Nutrition Assessment 1Flurandrenolone 1Exercise 1EOM613 1Diet, Carbohydrate-Restricted 1Diet 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Weight Loss × anamorelin × Clear all
NCT04844970 2025-11-17

Anamorelin Study for Advanced Pancreatic Cancer

Lahey Clinic

Phase 2 Terminated
4 enrolled 12 charts
Gastrointestinal

Anorexia, Cachexia, Pancreatic Neoplasms, Weight Loss

NCT03035409 2025-11-10

Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
129 enrolled 11 charts

Neoplasm Metastasis, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡